ReviewInflammopharmacology2026

Cucurbitacin derivatives (B, IIa, IIb, and E): modulating gut dysbiosis and inflammatory pathways for multi-target therapy of ulcerative colitis.

Radha Devi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.